Goldman Sachs
KANG

Goldman Sachs’s iKang Healthcare Group, Inc. KANG Stock Holding History

Goldman Sachs’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,100
Closed -$15K – 6865
2017
Q3 		$15K Hold
1,100
– – ﹤0.01% 6475
2017
Q2 		$13K Sell
1,100
-4,500
-80% -$65.2K ﹤0.01% 6630
2017
Q1 		$82K Sell
5,600
-5,700
-50% -$93.7K ﹤0.01% 6145
2016
Q4 		$196K Buy
11,300
+5,300
+88% +$89.7K ﹤0.01% 5784
2016
Q3 		$109K Buy
6,000
+600
+11% +$11K ﹤0.01% 6193
2016
Q2 		$99K Sell
5,400
-5,700
-51% -$115K ﹤0.01% 6135
2016
Q1 		$243K Buy
11,100
+7,600
+217% +$158K ﹤0.01% 5442
2015
Q4 		$72K Buy
3,500
+3,000
+600% +$51.8K ﹤0.01% 6352
2015
Q3 		$7K Buy
+500
New +$8.1K ﹤0.01% 7177

Goldman Sachs's KANG Position: Q1 2019 in Review

Goldman Sachs sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 4,372,992 shares — an estimated $89.1M sold.

Goldman Sachs first reported a position in KANG in Q3 2014 and held it in 18 quarters. The position peaked at $191M in Q1 2015. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.

  • Goldman Sachs reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
  • Goldman Sachs sold 4,372,992 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $89.1M.
  • Goldman Sachs first reported a position in iKang Healthcare Group, Inc. in Q3 2014 and held it in 18 quarters.
  • Goldman Sachs's iKang Healthcare Group, Inc. position peaked at $191M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.

Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.